Amitriptyline is a tricyclic antidepressant that treats depression, but today it’s more commonly prescribed at lower doses for chronic pain, migraines, irritable bowel syndrome, and insomnia. Originally developed in the 1960s as an antidepressant, its ability to influence pain signaling and sleep has made it one of the most versatile medications in primary care.
Depression
Amitriptyline’s original and FDA-approved use is for the treatment of major depressive disorder. It works by blocking the reabsorption of two chemical messengers in the brain, serotonin and norepinephrine, which allows more of these mood-regulating chemicals to remain active between nerve cells. This mechanism is similar to newer antidepressants, though amitriptyline also affects a wider range of receptors, which accounts for both its effectiveness and its broader side effect profile.
For depression, doses typically range much higher than the doses used for pain or sleep. In practice, newer antidepressants like SSRIs have largely replaced amitriptyline as a first-line depression treatment because they tend to cause fewer side effects. But amitriptyline remains a useful option when other antidepressants haven’t worked or when depression overlaps with chronic pain or insomnia.
Chronic Pain and Nerve Pain
Low-dose amitriptyline is widely prescribed off-label for various types of chronic pain, particularly nerve pain (neuropathy), fibromyalgia, and persistent tension-type headaches. At these lower doses, the drug appears to change the way the nervous system processes pain signals rather than simply acting as an antidepressant. The usual starting dose for pain is 10 mg per day, taken at bedtime, with a maximum of 75 mg per day.
Pain relief doesn’t happen overnight. It typically takes one to two weeks before pain starts to ease, and the full benefit can take four to six weeks to develop. The NHS advises giving amitriptyline at least six weeks before deciding whether it’s working for you. This gradual onset can be frustrating, but stopping too early is one of the most common reasons people miss out on its benefits.
Migraine Prevention
Amitriptyline is one of the most established medications for preventing migraines, not treating them once they start. It’s taken daily at a low dose to reduce the frequency and severity of attacks over time. The starting dose is the same 10 mg per day used for other pain conditions, though doses for migraine prevention can go higher than the 75 mg ceiling used for general pain management. Like its pain-relief effects, migraine prevention takes several weeks of consistent use to kick in.
Irritable Bowel Syndrome
A major 2023 trial published in The Lancet established low-dose amitriptyline as an effective second-line treatment for irritable bowel syndrome. The study, called ATLANTIS, enrolled 187 adults with IBS of any subtype whose symptoms hadn’t improved with dietary changes and first-line therapies. Participants started at 10 mg daily and could increase to 30 mg based on their symptoms and tolerability over three weeks, continuing for six months total.
The results were strong enough that the researchers recommended general practitioners offer low-dose amitriptyline to IBS patients who don’t respond to initial treatments. The trial even included a self-titration guide so patients could adjust their own dose within the prescribed range, making it practical for everyday primary care. Amitriptyline’s effect on gut nerves likely explains why it helps, since the same pain-modulating properties that work for neuropathy also calm the overactive nerve signaling in the digestive tract that drives IBS symptoms.
Insomnia
Because amitriptyline causes drowsiness as a side effect, it’s frequently prescribed off-label at very low doses (10 to 20 mg) for insomnia, especially in people who also have a chronic pain condition or another medical issue. A 2025 randomized trial compared 12 weeks of low-dose amitriptyline to cognitive behavioral therapy for insomnia (CBT-I, the gold-standard non-drug treatment) in 187 patients. Amitriptyline was found to be “non-inferior” to CBT-I for reducing insomnia severity, with only about a one-point difference on a standardized scale.
That said, CBT-I still had a meaningful edge: 58% of therapy participants achieved a strong clinical response, compared to 41% on amitriptyline. Amitriptyline did increase total sleep time more than therapy, which matters if you’re simply not sleeping enough hours. The bigger concern is what happens when you stop. In the trial, 68% of people who discontinued amitriptyline reported worsening sleep, and 63% experienced withdrawal-related complaints like fatigue, nervousness, headaches, and nightmares. Only 12% found the sleep worsening to be temporary. This makes amitriptyline a reasonable short-to-medium-term sleep option, but one that can be difficult to come off of.
How It Feels: Common Side Effects
Amitriptyline’s side effects stem largely from its influence on acetylcholine, a chemical messenger involved in many body functions beyond the brain. The most common complaints are dry mouth, drowsiness, difficulty waking up in the morning, increased appetite and weight gain, vivid dreams, difficulty urinating, constipation, and sweating. Most of these are dose-dependent, which is one reason pain and sleep prescriptions use much lower doses than depression prescriptions.
In the insomnia trial, 12% of participants stopped amitriptyline early due to side effects including dizziness, palpitations, nausea, and in a few cases, worsened mood. Heart-related effects like fast or irregular heartbeat and changes in blood pressure are also possible, which is why amitriptyline isn’t ideal for people with certain cardiac conditions. The drowsiness that makes it useful for sleep can be a problem during the day, so it’s almost always taken at bedtime regardless of the condition being treated.
Important Safety Considerations
All antidepressants, including amitriptyline, carry an FDA boxed warning about an increased risk of suicidal thoughts and behavior in children and adolescents. This applies regardless of whether the drug is being prescribed for depression, pain, or any other condition. Young people starting amitriptyline should be closely monitored, particularly during the first few months or whenever the dose changes. Families and caregivers are advised to watch for signs of clinical worsening, agitation, irritability, or unusual behavioral changes.
Amitriptyline should also be used cautiously in people with a history of seizures, urinary retention, or a specific type of glaucoma called angle-closure glaucoma. Stopping the medication abruptly after regular use can trigger withdrawal symptoms, so tapering the dose gradually under guidance is the standard approach.
Why Doses Vary So Much by Condition
One of the most confusing things about amitriptyline is the wide range of doses prescribed. Someone taking it for IBS might be on 10 to 30 mg, someone using it for nerve pain might take up to 75 mg, and someone being treated for depression could be on significantly more. These aren’t arbitrary differences. At lower doses, amitriptyline’s pain-modulating and sedating properties dominate. Higher doses are needed to produce enough serotonin and norepinephrine activity to shift mood in depression. The lower doses used for pain, IBS, and sleep also come with fewer and milder side effects, which is part of why these off-label uses have become so popular relative to the original antidepressant indication.